The Centers for Disease Control and Prevention (CDC) has provided information on a multistate outbreak of coagulopathy from exposure to synthetic cannabinoids products containing a vitamin K-epoxide cycle antagonist, brodifacoum. To learn more about this outbreak, and what you can do to help your patients who may be affected by it, please refer to the CDC?s alert.